Quantum Genomics SA
Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure. It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure. The company was incorporated in 2005 and is based in Paris, France. Show More...
-
Website https://www.quantum-genomics.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.07 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR -0.010 -0.36 -0.46 -0.54 -0.62 -0.85 -0.76 -0.5 -0.5 Dividends EUR Payout Ratio % * Shares Mil 68.0 4.0 5.0 7.0 8.0 11.0 16.0 18.0 18.0 Book Value Per Share * EUR -0.22 0.15 1.58 1.55 0.61 0.21 0.61 0.54 Free Cash Flow Per Share * EUR -0.010 -0.16 -0.22 -0.52 -0.47 -0.58 -0.34 -0.65 Return on Assets % -79.82 -112.13 -68.48 -49.23 -41.85 -66.0 -74.02 -54.06 -54.06 Financial Leverage (Average) 1.31 1.38 1.57 1.56 1.49 1.49 Return on Equity % -95.39 -56.52 -96.74 -115.63 -82.39 -82.39 Return on Invested Capital % -64.32 -56.8 -96.98 -115.7 -82.46 -82.46 Interest Coverage -56.92 -158.66 -127.1 -19.26 Current Ratio 0.56 0.44 0.99 5.6 5.08 3.57 3.36 3.6 3.6 Quick Ratio 0.53 0.17 0.85 4.92 4.64 3.36 3.16 3.34 3.34 Debt/Equity